Page last updated: 2024-11-04

temozolomide and Nephritis, Interstitial

temozolomide has been researched along with Nephritis, Interstitial in 1 studies

Nephritis, Interstitial: Inflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES and/or surrounding interstitium. For primary inflammation of glomerular interstitium, see GLOMERULONEPHRITIS. Infiltration of the inflammatory cells into the interstitial compartment results in EDEMA, increased spaces between the tubules, and tubular renal dysfunction.

Research Excerpts

ExcerptRelevanceReference
"We report a case of acute interstitial nephritis with associated nephrogenic diabetes insipidus in a patient treated with temozolomide and sulfamethoxazole-trimethoprim for glioblastoma multiforme."8.02Acute interstitial nephritis and nephrogenic diabetes insipidus following treatment with sulfamethoxazole-trimethoprim and temozolomide. ( Athavale, A; Gallagher, M; Jardine, M; Morris, J; Ritchie, A; Sen, S; Wang, AY, 2021)
"We report a case of acute interstitial nephritis with associated nephrogenic diabetes insipidus in a patient treated with temozolomide and sulfamethoxazole-trimethoprim for glioblastoma multiforme."4.02Acute interstitial nephritis and nephrogenic diabetes insipidus following treatment with sulfamethoxazole-trimethoprim and temozolomide. ( Athavale, A; Gallagher, M; Jardine, M; Morris, J; Ritchie, A; Sen, S; Wang, AY, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Athavale, A1
Morris, J1
Jardine, M1
Gallagher, M1
Sen, S1
Ritchie, A1
Wang, AY1

Other Studies

1 other study available for temozolomide and Nephritis, Interstitial

ArticleYear
Acute interstitial nephritis and nephrogenic diabetes insipidus following treatment with sulfamethoxazole-trimethoprim and temozolomide.
    Nephrology (Carlton, Vic.), 2021, Volume: 26, Issue:1

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Diab

2021